Cat /
FDA CVM · 2025 release 51 reports on file

Egyptian Mau - FDA Adverse Event Profile

Adverse-event records for Egyptian Mau (Cat) from the FDA Center for Veterinary Medicine.

Verify with FDA CVM →
Annual adverse-event report trend Yearly FDA CVM adverse-event report counts for this breed. 9 6.75 4.5 2.25 0 2017 2018 2019 2020 2022 2023 2024 2025 Reports filed Death-coded reports
Annual report volume for Egyptian Mau drawn from FDA CVM filings.

Data updated June 2026

The record at a glance

Egyptian Mau ranks #270 by report volume among cat breeds - 3 of 51 reports (5.9%) recorded a death outcome.

#270
most-reported cat breed
5.9%
death-coded report share
8
Application site hair loss - top reaction
7.1 yr
average age at report

Read report counts next to breed popularity: a bigger number often just means more owners and more vet visits.

Total Reports

51

FDA CVM filings

Deaths Reported

3

of 51 reports

Death Rate

5.9%

death-coded share

Avg Age at Report

7.1 yr

5.1 kg avg weight

Death-Coded Outcome Share

Egyptian Mau death-coded reports 5.9%
Cross-breed median

5.9% of 51 egyptian mau reports involved a death outcome.

How to read this number

Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (about 4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.

Average weight at time of report: 5.1 kg (11.2 lbs)

Top Reported Reactions

Application site hair loss 8
Vomiting 5
Lethargy (see also Central nervous system depression in 'Neurological') 4
Depression 3
Anorexia 3

Most Referenced Drugs

Selamectin;Sarolaner 8
Selamectin 6
Fluralaner Spot-On Solution 5
Cefovecin 5
Spinosad 4

Outcome Breakdown

Ongoing
22 (46.8%)
Outcome Unknown
15 (31.9%)
Recovered/Normal
6 (12.8%)
Died
3 (6.4%)
Recovered with Sequela
1 (2.1%)

Gender Distribution

Male 30 (58.8%)
Female 19 (37.3%)
Unknown 1 (2.0%)
Mixed 1 (2.0%)

Reports by Year

Year Reports Trend
2010 2
2011 2
2012 1
2014 2
2015 1
2016 2
2017 9
2018 3
2019 6
2020 3
2022 4
2023 7
2024 6
2025 3

Egyptian Mau Pet Health Insights

Egyptian Mau accounts for 51 FDA adverse event reports, ranking #270 by volume among cat breeds, with 3 reports (5.9%) coded as a death outcome. Mean age at report: 7.1 years, average weight 5.1 kg (11.2 lbs).

Top reported signs: Application site hair loss (8), Vomiting (5), Lethargy (see also Central nervous system depression in 'Neurological') (4). Most-referenced drug: Selamectin;Sarolaner (8 reports), followed by Selamectin (6) and Fluralaner Spot-On Solution (5).

Outcome coding on 47 status-recorded reports is dominated by Ongoing (46.8%). Annual submissions ranged 2,010-2,025 across 14 years on file.

Cat Breeds With a Similar Report Volume

Frequently Asked Questions

How many FDA adverse event reports involve Egyptian Mau?
There are 51 adverse event reports involving Egyptian Mau in the FDA database, with 3 reports involving death (5.9% death rate). Egyptian Mau ranks #270 by report volume.
What are the most common adverse reactions reported for Egyptian Mau?
The most commonly reported adverse reactions for Egyptian Mau are Application site hair loss (8 reports), Vomiting (5 reports), Lethargy (see also Central nervous system depression in 'Neurological') (4 reports), Depression (3 reports), Anorexia (3 reports).
What drugs are most frequently associated with Egyptian Mau adverse events?
The drugs most frequently referenced in Egyptian Mau adverse event reports are Selamectin;Sarolaner (8 reports), Selamectin (6 reports), Fluralaner Spot-On Solution (5 reports), Cefovecin (5 reports), Spinosad (4 reports).
What is the average age of Egyptian Mau in adverse event reports?
The average age of Egyptian Mau at the time of adverse event reports is 7.1 years, with an average weight of 5.1 kg (11.2 lbs).
Does a high number of adverse event reports mean Egyptian Mau is unhealthy?
No. FDA adverse event reports are voluntarily submitted and do not prove causation. Popular breeds with more veterinary visits tend to have more reports. The data reflects reporting patterns, not actual incidence rates. Always consult a veterinarian for health decisions.
Where does this Egyptian Mau safety data come from?
All data comes from the FDA Center for Veterinary Medicine's adverse event reporting system. Pet owners, veterinarians, and manufacturers voluntarily submit reports about adverse events potentially linked to animal drugs and other products.

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. Breed figures are computed directly from FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.